The raw waveform data (provided by customer) was analyzed.
Based on the limited information available, it is possible a blood clot or sample injection issue occurred on the test in question, indicating more of a sample handling/user injection related issue than a product deficiency.
The cause of the discrepancy could not be determined.
A review of the in-house performance of the card lot in use, lot 00-19193-10, did not identify any product deficiencies.
In addition, a search of the complaint handling system (gsms) for the card lot did not return any other related complaints.
Therefore, we conclude that there is no indication of a failure of the system to perform as intended.
The customer is operational.
|